165 related articles for article (PubMed ID: 36017234)
1. Evaluation of the Use of Brinzolamide-Brimonidine Fixed Combination in Maximum Medical Therapy.
Tekeli O; Köse HC
Turk J Ophthalmol; 2022 Aug; 52(4):262-269. PubMed ID: 36017234
[TBL] [Abstract][Full Text] [Related]
2. Twice-daily brinzolamide/brimonidine fixed combination versus brinzolamide or brimonidine in open-angle glaucoma or ocular hypertension.
Aung T; Laganovska G; Hernandez Paredes TJ; Branch JD; Tsorbatzoglou A; Goldberg I
Ophthalmology; 2014 Dec; 121(12):2348-55. PubMed ID: 25064721
[TBL] [Abstract][Full Text] [Related]
3. Randomized trial of brinzolamide/brimonidine versus brinzolamide plus brimonidine for open-angle glaucoma or ocular hypertension.
Gandolfi SA; Lim J; Sanseau AC; Parra Restrepo JC; Hamacher T
Adv Ther; 2014 Dec; 31(12):1213-27. PubMed ID: 25430900
[TBL] [Abstract][Full Text] [Related]
4. Brinzolamide/brimonidine fixed-dose combination bid as an adjunct to a prostaglandin analog for open-angle glaucoma/ocular hypertension.
Topouzis F; Goldberg I; Bell K; Tatham AJ; Ridolfi A; Hubatsch D; Nicolela M; Denis P; Lerner SF
Eur J Ophthalmol; 2021 Jan; 31(1):103-111. PubMed ID: 31595773
[TBL] [Abstract][Full Text] [Related]
5. Real-life experience of using brinzolamide/brimonidine fixed drop combination in a tertiary glaucoma centre.
Kóthy P; Holló G
Int Ophthalmol; 2020 Feb; 40(2):377-383. PubMed ID: 31650353
[TBL] [Abstract][Full Text] [Related]
6. The Efficacy and Safety of the Fixed Combination of Brinzolamide 1% and Brimonidine 0.2% in Normal Tension Glaucoma: An 18-Month Retrospective Study.
Jin SW; Lee SM
J Ocul Pharmacol Ther; 2018 Apr; 34(3):274-279. PubMed ID: 29297751
[TBL] [Abstract][Full Text] [Related]
7. Phase 3 randomized 3-month trial with an ongoing 3-month safety extension of fixed-combination brinzolamide 1%/brimonidine 0.2%.
Nguyen QH; McMenemy MG; Realini T; Whitson JT; Goode SM
J Ocul Pharmacol Ther; 2013 Apr; 29(3):290-7. PubMed ID: 23425430
[TBL] [Abstract][Full Text] [Related]
8. Fixed-combination brinzolamide 1%/brimonidine 0.2% vs monotherapy with brinzolamide or brimonidine in patients with open-angle glaucoma or ocular hypertension: results of a pooled analysis of two phase 3 studies.
Realini T; Nguyen QH; Katz G; DuBiner H
Eye (Lond); 2013 Jul; 27(7):841-7. PubMed ID: 23640612
[TBL] [Abstract][Full Text] [Related]
9. 24-Hour Intraocular Pressure Control with Fixed-dose Combination Brinzolamide 1%/Brimonidine 0.2%: A Multicenter, Randomized Trial.
Weinreb RN; Bacharach J; Fechtner RD; Kahook MY; Wirta D; Burmaster S; Meng X; Hubatsch DA
Ophthalmology; 2019 Aug; 126(8):1095-1104. PubMed ID: 30403988
[TBL] [Abstract][Full Text] [Related]
10. A Randomized Trial of Fixed-Dose Combination Brinzolamide 1%/Brimonidine 0.2% as Adjunctive Therapy to Travoprost 0.004.
Feldman RM; Katz G; McMenemy M; Hubatsch DA; Realini T
Am J Ophthalmol; 2016 May; 165():188-97. PubMed ID: 26940161
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of fixed-combination brinzolamide/timolol in Latin American patients with open-angle glaucoma or ocular hypertension previously on brimonidine/timolol fixed combination.
Alezzandrini A; Hubatsch D; Alfaro R
Adv Ther; 2014 Sep; 31(9):975-85. PubMed ID: 25138224
[TBL] [Abstract][Full Text] [Related]
12. Intraocular pressure-lowering effects and safety of brimonidine/brinzolamide fixed combination after switching from other medications.
Inoue K; Kunimatsu-Sanuki S; Ishida K; Tomita G
Jpn J Ophthalmol; 2022 Sep; 66(5):440-446. PubMed ID: 35842568
[TBL] [Abstract][Full Text] [Related]
13. Ocular hypotensive effect of fixed-combination brinzolamide/brimonidine adjunctive to a prostaglandin analog: a randomized clinical trial.
Fechtner RD; Myers JS; Hubatsch DA; Budenz DL; DuBiner HB
Eye (Lond); 2016 Oct; 30(10):1343-1350. PubMed ID: 27367743
[TBL] [Abstract][Full Text] [Related]
14. Additive effects of brimonidine tartrate 0.1%/brinzolamide 1% fixed-dose combination in prostaglandin analog-treated Japanese glaucoma patients.
Sakata R; Mizoue S; Yoshikawa K; Adachi M; Ohkubo S; Hamada N; Naito T; Muramatsu T; Hara T; Asato R; Aihara M
Jpn J Ophthalmol; 2023 Nov; 67(6):668-677. PubMed ID: 37596444
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of a fixed combination of 1% brinzolamide and 0.1% brimonidine as treatment for glaucoma: a retrospective study focusing on the number of ingredients.
Aoki R; Terao E; Dote S; Shiraishi M; Oogi S; Ueda K; Kimura Y; Nagata Y; Nakakura S
BMJ Open Ophthalmol; 2022 Dec; 7(1):. PubMed ID: 36799023
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the Intraocular Pressure-Lowering Efficacy and Safety of the Brinzolamide/Brimonidine Fixed-Dose Combination versus Concomitant Use of Brinzolamide and Brimonidine for Management of Open-Angle Glaucoma or Ocular Hypertension.
Wang N; Lu DW; Pan Y; Astakhov Y; Iureva T; Adewale A; Walker TM
Clin Ophthalmol; 2020; 14():221-230. PubMed ID: 32158181
[TBL] [Abstract][Full Text] [Related]
17. The 24-Hour Effects of Brinzolamide/Brimonidine Fixed Combination and Timolol on Intraocular Pressure and Ocular Perfusion Pressure.
Seibold LK; DeWitt PE; Kroehl ME; Kahook MY
J Ocul Pharmacol Ther; 2017 Apr; 33(3):161-169. PubMed ID: 28129020
[TBL] [Abstract][Full Text] [Related]
18. Brinzolamide plus brimonidine for the treatment of glaucoma: an update.
Chew SK; Skalicky SE; Goldberg I
Expert Opin Pharmacother; 2014 Nov; 15(16):2461-71. PubMed ID: 25267543
[TBL] [Abstract][Full Text] [Related]
19. Three-month randomized trial of fixed-combination brinzolamide, 1%, and brimonidine, 0.2%.
Katz G; Dubiner H; Samples J; Vold S; Sall K
JAMA Ophthalmol; 2013 Jun; 131(6):724-30. PubMed ID: 23579344
[TBL] [Abstract][Full Text] [Related]
20. Brinzolamide/brimonidine: a review of its use in patients with open-angle glaucoma or ocular hypertension.
Greig SL; Deeks ED
Drugs Aging; 2015 Mar; 32(3):251-60. PubMed ID: 25732405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]